Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors - PubMed (original) (raw)
Review
. 2001 Jan 18;20(3):395-8.
doi: 10.1038/sj.onc.1204055.
Affiliations
- PMID: 11313969
- DOI: 10.1038/sj.onc.1204055
Review
Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors
M V Blagosklonny. Oncogene. 2001.
Abstract
Recently it has been shown that the VHL tumor suppressor targets the hypoxia-inducible transcription factor (HIF-1) for ubiquitin-dependent degradation by the proteasome. Past mysteries of the p53 tumor suppressor help to solve the present puzzles of the VHL tumor suppressor. Thus, Mdm-2 targets the p53 tumor suppressor for ubiquitin-dependent degradation by the proteasome, but, in addition, the p53 transcription factor induces Mdm-2, thus, establishing a feedback loop. Hypoxia or DNA damage by abrogating binding of HIF-1 with VHL and p53 with Mdm-2, respectively, leads to stabilization and accumulation transcriptionally active HIF-1 and p53. More detailed analysis depicts the VHL/HIF-1 pair as the p53/mdm-2 pair that is turned upside down, suggesting that VHL may be a HIF-1-inducible gene of the feedback loop. The extended model proposes that an oncoprotein and a tumor suppressor due to transactivation coupled with feedback protein degradation might form functional pairs (Rb/E7, E2F/Rb, E2F/Mdm-2, catenin/APC, p27, cyclin D1, Rb/gankyrin), thus, predicting missing links.
Similar articles
- Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K, Makino Y, Pereira T, Poellinger L. Tanimoto K, et al. EMBO J. 2000 Aug 15;19(16):4298-309. doi: 10.1093/emboj/19.16.4298. EMBO J. 2000. PMID: 10944113 Free PMC article. - Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA, Ohh M. Maynard MA, et al. Am J Nephrol. 2004 Jan-Feb;24(1):1-13. doi: 10.1159/000075346. Epub 2003 Dec 3. Am J Nephrol. 2004. PMID: 14654728 Review. - The von Hippel-Lindau tumor suppressor gene.
Kondo K, Kaelin WG Jr. Kondo K, et al. Exp Cell Res. 2001 Mar 10;264(1):117-25. doi: 10.1006/excr.2000.5139. Exp Cell Res. 2001. PMID: 11237528 Review.
Cited by
- Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia.
Comerford KM, Leonard MO, Karhausen J, Carey R, Colgan SP, Taylor CT. Comerford KM, et al. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):986-91. doi: 10.1073/pnas.0337412100. Epub 2003 Jan 27. Proc Natl Acad Sci U S A. 2003. PMID: 12552083 Free PMC article. - Dynamics of DNA damage induced pathways to cancer.
Tian K, Rajendran R, Doddananjaiah M, Krstic-Demonacos M, Schwartz JM. Tian K, et al. PLoS One. 2013 Sep 4;8(9):e72303. doi: 10.1371/journal.pone.0072303. eCollection 2013. PLoS One. 2013. PMID: 24023735 Free PMC article. - Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.
Amelio I, Landré V, Knight RA, Lisitsa A, Melino G, Antonov AV. Amelio I, et al. Oncotarget. 2015;6(12):9646-56. doi: 10.18632/oncotarget.3917. Oncotarget. 2015. PMID: 25991664 Free PMC article. Review. - Role of compartmentalization on HiF-1α degradation dynamics during changing oxygen conditions: a computational approach.
Bedessem B, Stéphanou A. Bedessem B, et al. PLoS One. 2014 Oct 22;9(10):e110495. doi: 10.1371/journal.pone.0110495. eCollection 2014. PLoS One. 2014. PMID: 25338163 Free PMC article. - Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia.
Bagnall J, Leedale J, Taylor SE, Spiller DG, White MR, Sharkey KJ, Bearon RN, Sée V. Bagnall J, et al. J Biol Chem. 2014 Feb 28;289(9):5549-64. doi: 10.1074/jbc.M113.500405. Epub 2014 Jan 6. J Biol Chem. 2014. PMID: 24394419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous